My 6-Year-Old Son Drowned In Our Pool. Here's What I Wish I Had Known To Keep Him Safe. Cathie Wood buys $13.9 million of popular AI stock 13 Things to Do in Las Vegas That Don’t Involve Casinos ...

Hurricane season is here, and the nation's top forecaster has an urgent message Cathie Wood buys $13.9 million of popular AI stock Cowboys set to lose $16.4 million in future cap space Tuesday ...

ROGELIO "Jay-R" Esquivel captured a bronze medal, and Team Philippines took home a bronze in the last day of International Surfing Association (ISA) World Longboard Championships finals held at the El ...

MANILA, Philippines — The Philippines settled for bronze in the International Surfing Association World Longboard Championships in El Salvador. The Philippines, which barely held on to the top ...

Following the IOC's decision to exclude longboard from the Los Angeles 2028 programme, the ISA has issued an official statement reaffirming its commitment to the discipline, focusing on the ...

In a significant corporate development, Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) has finalized its acquisition by H. Lundbeck A/S, a Danish pharmaceutical firm, as of Monday. This transaction ...

Longboard Pharmaceuticals Inc. has reached an unprecedented milestone as its stock price soared to an all-time high of $59.96. This remarkable peak reflects a staggering 1-year change of 1457.14% ...

Lundbeck will buy Longboard Pharmaceuticals and its 5-HT 2C receptor agonist bexicaserin, which is currently in phase III development for seizures associated with Dravet syndrome. The deal ...

Denmark’s Lundbeck is set to acquire Longboard Pharmaceuticals for about $2.5 billion. California-based Longboard has a small molecule, bexicaserin, in late-stage clinical trials for certain ...

Two Southern California surfers have claimed the 2024 World Surf League’s World Longboard Championship – a second win for Dana Point native Rachael Tilly and a fourth for San Diego’s Taylor ...

Longboard Pharmaceuticals LBPH announced that it is set to be acquired by Lundbeck A/S for $60 per share in cash, which brings the total deal value to $2.6 billion equity value and $2.5 billion ...

Lundbeck announced this week that it will acquire Longboard Pharmaceuticals in a $2.6 billion deal, picking up the epilepsy drug bexicaserin in the process. The move — the largest to date for the ...